Complementary in vitro and in vivo studies in primary-derived mouse and established human melanoma cell lines confirmed LOXL3 contribution to melanoma progression, in part by modulating melanoma phenotypic plasticity by regulating the expression of SNAIL1 and PRRX1 EMT-TFs. This evidence concerns the gene LOXL3 and melanoma.